159 related articles for article (PubMed ID: 15994797)
1. Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.
Ott DE; Coren LV; Gagliardi TD; Nagashima K
J Virol; 2005 Jul; 79(14):9038-45. PubMed ID: 15994797
[TBL] [Abstract][Full Text] [Related]
2. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.
Li F; Chen C; Puffer BA; Montelaro RC
J Virol; 2002 Feb; 76(4):1569-77. PubMed ID: 11799151
[TBL] [Abstract][Full Text] [Related]
3. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
Puffer BA; Parent LJ; Wills JW; Montelaro RC
J Virol; 1997 Sep; 71(9):6541-6. PubMed ID: 9261374
[TBL] [Abstract][Full Text] [Related]
4. Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release.
Wang H; Machesky NJ; Mansky LM
J Virol; 2004 Feb; 78(3):1503-12. PubMed ID: 14722305
[TBL] [Abstract][Full Text] [Related]
5. Late domain-dependent inhibition of equine infectious anemia virus budding.
Shehu-Xhilaga M; Ablan S; Demirov DG; Chen C; Montelaro RC; Freed EO
J Virol; 2004 Jan; 78(2):724-32. PubMed ID: 14694104
[TBL] [Abstract][Full Text] [Related]
6. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
[TBL] [Abstract][Full Text] [Related]
7. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release.
Gottwein E; Bodem J; Müller B; Schmechel A; Zentgraf H; Kräusslich HG
J Virol; 2003 Sep; 77(17):9474-85. PubMed ID: 12915562
[TBL] [Abstract][Full Text] [Related]
8. A bipartite late-budding domain in human immunodeficiency virus type 1.
Martin-Serrano J; Bieniasz PD
J Virol; 2003 Nov; 77(22):12373-7. PubMed ID: 14581576
[TBL] [Abstract][Full Text] [Related]
9. Identification of retroviral late domains as determinants of particle size.
Garnier L; Parent LJ; Rovinski B; Cao SX; Wills JW
J Virol; 1999 Mar; 73(3):2309-20. PubMed ID: 9971814
[TBL] [Abstract][Full Text] [Related]
10. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
Goila-Gaur R; Demirov DG; Orenstein JM; Ono A; Freed EO
J Virol; 2003 Jun; 77(11):6507-19. PubMed ID: 12743307
[TBL] [Abstract][Full Text] [Related]
11. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
Demirov DG; Orenstein JM; Freed EO
J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
[TBL] [Abstract][Full Text] [Related]
12. Retroviruses have differing requirements for proteasome function in the budding process.
Ott DE; Coren LV; Sowder RC; Adams J; Schubert U
J Virol; 2003 Mar; 77(6):3384-93. PubMed ID: 12610113
[TBL] [Abstract][Full Text] [Related]
13. A role for ubiquitin ligase recruitment in retrovirus release.
Strack B; Calistri A; Accola MA; Palu G; Gottlinger HG
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13063-8. PubMed ID: 11087860
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
Demirov DG; Ono A; Orenstein JM; Freed EO
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
[TBL] [Abstract][Full Text] [Related]
15. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
Johnson MC; Spidel JL; Ako-Adjei D; Wills JW; Vogt VM
J Virol; 2005 Mar; 79(6):3775-86. PubMed ID: 15731271
[TBL] [Abstract][Full Text] [Related]
17. In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.
Patnaik A; Wills JW
J Virol; 2002 Mar; 76(6):2789-95. PubMed ID: 11861846
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent effects of L domains and ubiquitination on viral budding.
Martin-Serrano J; Perez-Caballero D; Bieniasz PD
J Virol; 2004 Jun; 78(11):5554-63. PubMed ID: 15140952
[TBL] [Abstract][Full Text] [Related]
19. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells.
Kikonyogo A; Bouamr F; Vana ML; Xiang Y; Aiyar A; Carter C; Leis J
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11199-204. PubMed ID: 11562473
[TBL] [Abstract][Full Text] [Related]
20. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release.
Dorweiler IJ; Ruone SJ; Wang H; Burry RW; Mansky LM
J Virol; 2006 Apr; 80(7):3634-43. PubMed ID: 16537631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
